Prediction of Cancer Incidence and Mortality in Korea, 2020

Kyu-Won Jung; Young-Joo Won; Seri Hong; Hyun-Joo Kong; Eun Sook Lee

doi:10.4143/crt.2020.203

Articles

Page Path: HOME > Cancer Res Treat > Volume 52(2); 2020 > Article

Special Article Prediction of Cancer Incidence and Mortality in Korea, 2020: Kyu-Won Jung, MS^1,2, Young-Joo Won, PhD^1,2,3,, Seri Hong, MD, PhD^1,2, Hyun-Joo Kong, MS^1,2, Eun Sook Lee, MD, PhD^1,4; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2020;52(2):351-358.
DOI: https://doi.org/10.4143/crt.2020.203
Published online: March 16, 2020

¹Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

²Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea

³Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

⁴National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Correspondence: Young-Joo Won, PhD Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr

• Received: March 9, 2020 • Accepted: March 15, 2020

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

16,852 Views
531 Download
129 Web of Science
122 Crossref
128 Scopus

prev next

Full Article

Download PDF

Abstract

Purpose
This study aimed to report the projected cancer incidence and mortality for the year 2020 to estimate Korea’s current cancer burden.
Materials and Methods
Cancer incidence data from 1999 to 2017 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2018 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against observed years and then by multiplying the projected age-specific rates by the age-specific population. A Joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend.
Results
In total, 243,263 new cancer cases and 80,546 cancer deaths are expected to occur in Korea in 2020. The most common cancer site is expected to be the lung, followed by the stomach, thyroid, colon/rectum, and breast. These five cancers types are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer among people who die is expected to be lung cancer, followed by liver, colon/rectal, pancreatic, and stomach cancers.
Conclusion
The incidence rates for all types of cancer in Korea are estimated to decrease gradually. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.
Key words: Incidence, Mortality, Neoplasms, Forecasting, Korea, 2020

Introduction

As the leading cause of death in Korea [1], cancer has been a major public health concern in the country since 1983. In 2016, over 220,000 patients were newly diagnosed with cancer in Korea, and one-fourth of deaths were due to cancer [2]. Although the cancer registration system in Korea is highly efficient and can provide nationwide cancer statistics within a relatively short period, a lag time of at least 2 years is required to collect and analyze data for a specific year. For planning and implementing comprehensive cancer-control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2020 based on data from the 1990s to 2018.

Materials and Methods

The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, known as the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere [3]. Cancer incidence data from 1999 to 2017 were obtained from the Korea National Cancer Incidence Database (KNCI DB). Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [4] and converted according to the International Classification of Diseases, 10th edition (ICD-10) [5]. Mortality data from 1993 to 2018 were acquired from Statistics Korea [1]. The cause of death was coded and classified according to the ICD-10 code [5].

The cancer sites included in this study were (1) all cancers sites combined and (2) the 24 most common cancer sites as follows: lips, oral cavity, and pharynx (C00-C14); esophagus (C15); stomach (C16); colon and rectum (C18-C20); liver (C22); gallbladder, etc. (C23-C24); pancreas (C25); larynx (C32); lung (C33-C34); breast (C50); cervix uteri (C53); corpus uteri (C54); ovary (C56); prostate (C61); testis (C62); kidney (C64); bladder (C67); brain and central nervous system (C70-C72); thyroid (C73); Hodgkin lymphoma (C81); non-Hodgkin lymphoma (C82-C86, C96); multiple myeloma (C90); leukemia (C91-C95); and “other and ill defined (remainder of C00-C96)” sites.

Population data from 1993 to 2020 were obtained from the resident registration population data, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed for the denominator. However, we used population data as of December 31, 2019 for the year 2020, because mid-2020 resident registration population data were not yet available at the time of the analysis.

Linear regression models [6] were used to assess time trends and create projections. We first performed a Joinpoint regression analysis on the data available to detect the year when significant changes occurred in cancer trends according to sex and cancer site. A Joinpoint regression describes changes in data trends by connecting several different line segments on a log scale at “joinpoints.” This analysis was performed using the Joinpoint software (ver. 4.7.0.0, http://surveillance.cancer.gov/joinpoint) from the Surveillance Research Program of the US National Cancer Institute [7]. For the analysis, we arranged to have at least four data points between consecutive joinpoints. Secondly, to predict age-specific cancer rates, a linear regression model was fitted to age-specific rates by 5-year age groups against the observed years, based on the observed cancer incidence data of the latest trends, with the exception of the incidence of thyroid cancer. We used average age-specific rates from recent three consecutive years (2015-2017), taking into consideration the recent trends in the incidence rate of thyroid cancer.

Finally, we multiplied the projected age-specific rates by the age-specific population to get the projected number of cancer cases and deaths for the year 2020.

We summarized the results using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population [8] and are expressed per 100,000 persons.

Results

1. Incidence

In total, 243,263 new cancer cases are expected to occur in 2020 (Table 1, Fig. 1); more men (n=126,098) than women (n=117,165) are expected to be affected.

The projected CRs per 100,000 for all of the sites combined in 2020 are 487.5 and 450.9 in men and women, respectively (Table 2). The projected ASRs per 100,000 for all of the sites combined are 268.7 and 250.9 in men and women, respectively. In men, the five leading primary sites of cancer are expected to be the lung (CR, 78.6; ASR, 39.9), stomach (CR, 69.2; ASR, 37.2), colon and rectum (CR, 57.2; ASR, 30.5), prostate (CR, 56.3; ASR, 28.7), and liver (CR, 42.5; ASR, 22.9), accounting for 62.3% of all new cancer cases in 2020 (Fig. 1A). In women, the five leading primary sites are expected to be the breast (CR, 98.0; ASR, 61.0), thyroid (CR, 80.3; ASR, 57.5), colon and rectum (CR, 42.7; ASR, 18.3), stomach (CR, 35.1; ASR, 16.5), and lung (CR, 34.5; ASR, 15.2), accounting for 64.4% of all new cancer cases in 2020 (Fig. 1B).

The five most common cancer sites expected in 2020, according to sex and age groups, are shown in Table 3. Leukemia and thyroid cancer are expected to be the most common forms of cancer in both sexes for the 0-14 and 15-34 age groups, respectively. Stomach cancer is predicted to be the most prevalent cancer in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 years and above. Breast cancer is predicted to be the most common cancer in women aged 35-64 years, whereas colorectal cancer is expected to be the most prevalent in women aged 65 years and above. These projections indicate that the incidences of stomach, lung, liver, colorectal, and prostate cancers will increase gradually with age in men (Fig. 2A). In women, the age-specific incidence rates for stomach, colorectal, liver, lung, and cervical cancers denote an increasing trend with age; however, the incidences of breast and thyroid cancers in women are expected to level off after the age of 40 years (Fig. 2B).

2. Mortality

It is estimated that 80,546 cancer deaths will occur in Korea during 2020 (Table 1, Fig. 1). The projected CRs per 100,000 for all of the sites combined in 2020 for men and women are 190.5 and 120.3, respectively, whereas the projected ASRs per 100,000 for all of the sites combined for men and women are expected to be 98.0 and 48.2, respectively (Table 4). The predicted five leading cancer sites causing mortality in men are the lung (CR, 54.9; ASR, 27.2), liver (CR, 27.4; ASR, 14.6), colon and rectum (CR, 18.7; ASR, 9.6), stomach (CR, 15.7; ASR, 8.1), and pancreas (CR, 13.5; ASR, 7.0). During the same period, lung cancer (CR, 17.7; ASR, 6.3) is projected to be the leading cause of cancer death in women, followed by colon and rectal (CR, 15.1; ASR, 5.2), pancreatic (CR, 12.9; ASR, 4.8), liver (CR, 11.1; ASR, 4.0), and breast (CR, 10.6; ASR, 6.1) cancers.

The predicted age-specific mortality rates of the leading cause of cancer death in men and women in 2020 are shown in further detail in Fig. 3. According to age, Korean men and women aged at least 60 years are expected to have the highest mortality rates due to lung cancer.

Conclusion

A total of 243,263 new cancer cases and 80,546 cancer deaths are expected to occur in Korea during 2020. Lung cancer is predicted to be the most common type of cancer among men, followed by stomach, colorectal, prostate, and liver cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary cancer sites are expected to be the breast, thyroid, colorectum, stomach, and lung, while lung, colorectal, pancreatic, liver, and breast cancers are projected to be the most common causes of cancer deaths.

Cancer is currently one of the foremost public health concerns in Korea. Although cancer incidence rates are anticipated to decrease slightly, the burden of most types of cancers will continue to grow with the increasing age of the population. The current projections of cancer incidence and mortality for 2020 represent an important resource for planning and evaluating cancer-control programs. As the estimates in this study are model-based, these results should be interpreted with caution.

NOTES

Conflict of interest relevant to this article was not reported.

Acknowledgements

The authors would like to thank the tumor registrars (health information managers) of the KCCR-affiliated hospitals and non-KCCR-affiliated hospitals for their assistance with data collection, abstraction, and coding. Additionally, we acknowledge the cooperation of the National Health Insurance Service and Statistics Korea for their support with the data. This work was supported by the National Cancer Center research grant (No. 1910131).

Fig. 1.

The 10 leading types of estimated new cancer cases and deaths by sex in 2020. (A) Estimated new cases. (B) Estimated deaths.

Fig. 2.

Projected age-specific incidences of major cancers during 2020 in Korea. (A) Men. (B) Women.

Fig. 3.

Projected age-specific mortality rates of major cancers during 2020 in Korea. (A) Men. (B). Women.

Table 1.

Estimated new cancer cases and deaths by sex during 2020 in Korea

Site	Estimated new cases			Estimated deaths
Site	Both sexes	Men	Women	Both sexes	Men	Women
All sites	243,263	126,098	117,165	80,546	49,284	31,262
Lip, oral cavity, and pharynx	3,915	2,813	1,102	1,222	888	334
Esophagus	2,555	2,317	238	1,278	1,140	138
Stomach	27,005	17,889	9,116	6,279	4,060	2,219
Colon and rectum	25,881	14,789	11,092	8,758	4,847	3,911
Liver^a)	14,670	10,994	3,676	9,961	7,090	2,871
Gallbladder^b)	7,999	4,244	3,755	5,235	2,809	2,426
Pancreas	8,331	4,330	4,001	6,843	3,483	3,360
Larynx	1,085	1,020	65	266	252	14
Lung^c)	29,292	20,340	8,952	18,796	14,192	4,604
Breast	25,549	97	25,452	2,766	18	2,748
Cervix uteri	3,148	-	3,148	801	-	801
Corpus uteri	3,261	-	3,261	383	-	383
Ovary	2,941	-	2,941	1,309	-	1,309
Prostate	14,561	14,561	-	2,040	2,040	-
Testis	308	308	-	18	18	-
Kidney	5,923	4,003	1,920	1,198	813	385
Bladder	4,832	3,870	962	1,622	1,229	393
Brain and CNS	2,122	1,140	982	1,351	703	648
Thyroid	26,747	5,884	20,863	350	100	250
Hodgkin lymphoma	342	214	128	72	43	29
Non-Hodgkin lymphoma	5,484	3,161	2,323	2,145	1,230	915
Multiple myeloma	1,963	1,019	944	1,153	624	529
Leukemia	3,766	2,167	1,599	2,041	1,187	854
Other and ill defined	21,583	10,938	10,645	4,659	2,518	2,141

CNS, central nervous system.

^a) Includes the liver and intrahepatic bile duct,

^b) Includes the gallbladder and other/unspecified parts of the biliary tract,

^c) Includes the lung and bronchus.

Table 2.

Estimated crude and age-standardized cancer incidences by sex during 2020 in Korea

Site	Crude incidence rate per 100,000			Age-standardized incidence rate per 100,000^a)
Site	Both sexes	Men	Women	Both sexes	Men	Women
All sites	469.2	487.5	450.9	253.7	268.7	250.9
Lip, oral cavity, and pharynx	7.6	10.9	4.2	4.2	6.2	2.4
Esophagus	4.9	9.0	0.9	2.4	4.6	0.4
Stomach	52.1	69.2	35.1	27.1	37.2	16.5
Colon and rectum	49.9	57.2	42.7	24.2	30.5	18.3
Liver^b)	28.3	42.5	14.2	14.8	22.9	6.0
Gallbladder^c)	15.4	16.4	14.5	6.7	8.3	5.4
Pancreas	16.1	16.7	15.4	7.3	8.8	6.2
Larynx	2.1	3.9	0.3	1.1	2.0	0.1
Lung^d)	56.5	78.6	34.5	25.9	39.9	15.2
Breast	49.3	0.4	98.0	29.3	0.2	61.0
Cervix uteri	6.1	-	12.1	3.5	-	7.8
Corpus uteri	6.3	-	12.6	3.6	-	7.6
Ovary	5.7	-	11.3	3.4	-	7.0
Prostate	28.1	56.3	-	12.4	28.7	-
Testis	0.6	1.2	-	0.6	1.2	-
Kidney	11.4	15.5	7.4	6.2	9.1	4.0
Bladder	9.3	15.0	3.7	4.3	7.6	1.5
Brain and CNS	4.1	4.4	3.8	3.0	3.3	2.7
Thyroid	51.6	22.8	80.3	36.4	16.0	57.5
Hodgkin lymphoma	0.7	0.8	0.5	0.6	0.7	0.5
Non-Hodgkin lymphoma	10.6	12.2	8.9	6.3	7.9	5.1
Multiple myeloma	3.8	3.9	3.6	1.9	2.1	1.6
Leukemia	7.3	8.4	6.2	5.5	6.6	4.6
Other and ill defined	41.6	42.3	41.0	22.1	24.8	19.5

CNS, central nervous system.

^a) Age adjusted to the world standard population,

^b) Includes the liver and intrahepatic bile duct,

^c) Includes the gallbladder and other/unspecified parts of the biliary tract,

^d) Includes the lung and bronchus.

Table 3.

Estimated cancer incidence by age group and sex during 2020 in Korea

Rank	Age group (yr)
Rank	0-14	15-34	35-64	≥ 65
Men
1	Leukemia (4.9)	Thyroid (13.7)	Stomach (66.3)	Lung^a) (428.6)
2	Non-Hodgkin lymphoma (3.1)	Leukemia (3.8)	Colon and rectum (48.3)	Prostate (323.0)
3	Brain and CNS (2.3)	Non-Hodgkin lymphoma (3.2)	Liver^b) (44.2)	Stomach (276.7)
4	Kidney (0.4)	Testis (2.7)	Lung^a) (43.8)	Colon and rectum (248.7)
5	Liver^b) (0.3)	Colon and rectum (2.4)	Prostate (27.2)	Liver^b) (156.8)
Women
1	Leukemia (4.0)	Thyroid (50.0)	Breast (164.1)	Colon and rectum (157.3)
2	Brain and CNS (2.1)	Breast (12.0)	Thyroid (126.6)	Lung^a) (124.3)
3	Non-Hodgkin lymphoma (1.7)	Cervix uteri (5.5)	Stomach (31.7)	Stomach (112.3)
4	Ovary (0.8)	Ovary (3.4)	Colon and rectum (30.9)	Breast (101.3)
5	Thyroid (0.7)	Corpus uteri (2.5)	Lung^a) (26.3)	Gallbladder^c) (65.6)

CNS, central nervous system.

^a) Includes the lung and bronchus,

^b) Includes the liver and intrahepatic bile duct,

^c) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 4.

Estimated crude and age-standardized cancer mortality rates by sex during 2020 in Korea

Site	Crude mortality rate per 100,000			Age-standardized mortality rate per 100,000^a)
Site	Both sexes	Men	Women	Both sexes	Men	Women
All sites	155.3	190.5	120.3	69.4	98.0	48.2
Lip, oral cavity, and pharynx	2.4	3.4	1.3	1.1	1.8	0.6
Esophagus	2.5	4.4	0.5	1.1	2.2	0.2
Stomach	12.1	15.7	8.5	5.3	8.1	3.1
Colon and rectum	16.9	18.7	15.1	7.2	9.6	5.2
Liver^b)	19.2	27.4	11.1	9.0	14.6	4.0
Gallbladder^c)	10.1	10.9	9.3	4.1	5.4	3.0
Pancreas	13.2	13.5	12.9	5.8	7.0	4.8
Larynx	0.5	1.0	0.1	0.2	0.5	0.0
Lung^d)	36.3	54.9	17.7	15.2	27.2	6.3
Breast	5.3	0.1	10.6	3.1	0.0	6.1
Cervix uteri	1.5	-	3.1	0.9	-	1.7
Corpus uteri	0.7	-	1.5	0.4	-	0.8
Ovary	2.5	-	5.0	1.3	-	2.5
Prostate	3.9	7.9	-	1.4	3.7	-
Testis	0.0	0.1	-	0.0	0.1	-
Kidney	2.3	3.1	1.5	1.1	1.7	0.6
Bladder	3.1	4.8	1.5	1.2	2.3	0.4
Brain and CNS	2.6	2.7	2.5	1.6	1.8	1.4
Thyroid	0.7	0.4	1.0	0.3	0.2	0.3
Hodgkin lymphoma	0.1	0.2	0.1	0.1	0.1	0.1
Non-Hodgkin lymphoma	4.1	4.8	3.5	1.9	2.5	1.4
Multiple myeloma	2.2	2.4	2.0	1.0	1.2	0.8
Leukemia	3.9	4.6	3.3	2.1	2.7	1.6
Other and ill defined	9.0	9.7	8.2	4.2	5.3	3.3

CNS, central nervous system.

^a) Age adjusted to the world standard population,

^b) Includes the liver and intrahepatic bile duct,

^c) Includes the gallbladder and other/unspecified parts of the biliary tract,

^d) Includes the lung and bronchus.

REFERENCES

1. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2020. [cited 2020 Feb 8]. Available from: http://kosis.kr
2. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat. 2019;51:417–30. Article PubMed PMC PDF
3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the National Cancer Incidence Database. Cancer Res Treat. 2005;37:325–31. Article PubMed PMC PDF
4. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st revision. Geneva: World Health Organization; 2013.
5. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization; 1994.
6. Boyle P, Parkin DM. Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ. 1991;(95):126–58. PubMed
7. National Cancer Institute. Joinpoint regression program, version 4.3.1 [Internet]. Bethesda, MD: National Cancer Institute; 2016. [cited 2019 Jul 8]. Available from: http://surveillance.cancer.gov/joinpoint/
8. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Incidence, trends and patterns of female breast, cervical, colorectal and prostate cancers in Antigua and Barbuda, 2017–2021: a retrospective study
Andre A. N. Bovell, Thendo Ramaliba, Sekeena O. Goodwin, Joycelyn C. Phillip, Jabulani Ncayiyana, Themba G. Ginindza
BMC Cancer.2025;[Epub] CrossRef
Oncologic outcomes of surgically treated colorectal cancer in octogenarians: a comparative study using inverse probability of treatment weighting (IPTW)
Soo Young Oh, Jung Yun Park, Kwan Mo Yang, Seong-A Jeong, Yong Jae Kwon, Yun Tae Jung, Chung Hyeun Ma, Keong Won Yun, Kwang Hyun Yoon, Jae Young Kwak, Chang Sik Yu
BMC Gastroenterology.2025;[Epub] CrossRef
A novel model for accurate and fast prediction of cancer incidence
Mahmoud Hamed, Berlanty A. Zayed, Fotouh R. Mansour
BMC Public Health.2025;[Epub] CrossRef
Connection between trajectory of primary cancer monitoring indicators and mortality after cancer in South Korea
Jung Hyun Kim, Haedong Kim, Man S. Kim, Mison Chun, Jaeyong Shin
BMC Medicine.2025;[Epub] CrossRef
Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021
Chengjun Hu, Weifeng Chen, Ping Zhang, Tongping Shen, Maozhong Xu, Victoria Pando-Robles
PLOS One.2025; 20(6): e0325937. CrossRef
Analysis of Histology of Post-Cholecystectomy Gallbladder Specimens at Mankweng Hospital
Lerato Hector Nong, Mirza Mohamod Zahir Uddin Bhuiyan
European Journal of Medical and Health Sciences.2025; 7(3): 55. CrossRef
Evaluation and forecasting methods to estimate number of patients with non-Hodgkin lymphoma: a systematic literature review
Dan Lin, Changxia Shao, James R. Rogers, Mehmet Burcu, Helmneh M. Sineshaw
Population Health Metrics.2025;[Epub] CrossRef
Association between different water iodine exposures and thyroid cancer: A retrospective study of high water iodine areas in China from 2009 to 2020
Yi Chen, Chunpeng Lv, Xiaodan Zhang, Kunying Yang, Jiahui Li, Zheng Shen, Li Ai, Dianjun Sun, Wei Zhang
Chemosphere.2024; 346: 140581. CrossRef
Potential role of Fibrosis‐4 score in hepatocellular carcinoma screening: The Kangbuk Samsung Health Study
Sujeong Shin, Won Sohn, Yoosoo Chang, Yoosun Cho, Min‐Jung Kwon, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu
Hepatology Research.2024; 54(6): 551. CrossRef
New findings in prognostic factor assessment for adenocarcinoma of transverse colon: a comparison study between competing-risk and COX regression analysis
Hongbo Su, Shuping Xie, Shanshan Wang, Liying Huang, Jun Lyu, Yunlong Pan
Frontiers in Medicine.2024;[Epub] CrossRef
GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure
Hoyeon Jeong, Young-Rae Cho, Jungsoo Gim, Seung-Kuy Cha, Maengsup Kim, Dae Ryong Kang, Kyle Ellrott
PLOS ONE.2024; 19(3): e0291223. CrossRef
Relationship between METS-IR and thyroid cancer incidence in Korea: a nationwide population-based study
Hye Ryeon Kim, Minkook Son, Seok Jae Huh, Sang Yi Moon, Hyeyeon Moon, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee
Frontiers in Oncology.2024;[Epub] CrossRef
The Expression and Amplification of HER2 Has a Significant Impact on the Prognosis of Endometrial Carcinoma in Korean Patients
Wook Youn Kim, Eun Jung Yang, Eun Bi Jang, A Jin Lee, Kyeong A So, Seung-Hyuk Shim, Tae Jin Kim, Sun Joo Lee
Journal of Clinical Medicine.2024; 13(8): 2158. CrossRef
Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study
Jiyun Lee, Hee Kyung Ahn, Sang‐We Kim, Ji‐Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo‐Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
Cancer Medicine.2024;[Epub] CrossRef
The burden and long-term trends of breast cancer by different menopausal status in China
Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Wenqiang Wei
Journal of the National Cancer Center.2024; 4(4): 326. CrossRef
Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018
Sara Kwon, Kyuwoong Kim, Bohyun Park, So-Jung Park, Hyun Jung Jho, Jin Young Choi
BMC Palliative Care.2024;[Epub] CrossRef
Standardized Mortality Ratios (SMRs) and Radon Exposure Analysis for Lung Cancer and All-Cause Mortality in Locorotondo, Southern Italy
Giovanni Maria Ferri, Luigi De Maria, Giuseppe Delvecchio, Antonio Caputi, Stefano Sole, Gianmarco Giannelli, Gianfranco Sifanno, Ilaria Maria Di Somma, Floriana Pentimone, Domenica Cavone, Angela Stufano, Piero Lovreglio, Vitantonio Ricci, Luigi Vimercat
Medicina.2024; 61(1): 47. CrossRef
IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC
Jee Hyun Kang, Suyoung Park, Jinhyung Rho, Eun-Ju Hong, Young-Eun Cho, Young-Suk Won, Hyo-Jung Kwon
Gastric Cancer.2023; 26(1): 82. CrossRef
Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital
Min Hyun Kim, Duck-Woo Kim, Hye Seung Lee, Su Kyung Bang, Soo Hyun Seo, Kyung Un Park, Heung-Kwon Oh, Sung-Bum Kang
Cancer Research and Treatment.2023; 55(1): 179. CrossRef
Outcomes of Palliative Colonic Stent Placement in Malignant Colonic Obstruction: Experience from a Tertiary Care Oncology Center in India
Sridhar Sundaram, Raosaheb Rathod, Prachi Patil, Kiran Mane, Vishal Seth, Avanish Saklani, Ashwin Desouza, Shaesta Mehta
Journal of Digestive Endoscopy.2023; 14(01): 008. CrossRef
Effect of a 1-year tailored exercise program according to cancer trajectories in patients with breast cancer: study protocol for a randomized controlled trial
Jiin Ryu, Eun-Young Lee, Jihee Min, Sujin Yeon, Ji-Won Lee, Sang Hui Chu, Hyangkyu Lee, Seung Il Kim, Jee Ye Kim, Seho Park, Justin Y. Jeon
BMC Cancer.2023;[Epub] CrossRef
Trends in Survival Rates of Non–Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020
Sang Ah Chi, Hyeyeon Yu, Yoon-La Choi, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Dae-Ho Choi, Kyunga Kim, Hyun Ae Jung, Keunchil Park
JAMA Network Open.2023; 6(3): e232002. CrossRef
Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
Yerim Cho, Su Bee Park, Jin Young Yoon, Min Seob Kwak, Jae Myung Cha
Medicine.2023; 102(11): e33279. CrossRef
Prediction of breast cancer using blood microbiome and identification of foods for breast cancer prevention
Jeongshin An, Jinho Yang, Hyungju Kwon, Woosung Lim, Yoon-Keun Kim, Byung-In Moon
Scientific Reports.2023;[Epub] CrossRef
Role of systemic immune-inflammation index in predicting mortality in cancer patients in palliative care units
Duygu TUTAN, Fatih ESKİN
Journal of Health Sciences and Medicine.2023; 6(2): 223. CrossRef
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study
Dong-Hoe Koo, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Eun-Gyeong Lee, Jai Hong Han, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Cheol-Young Park, Sang Woo Oh
Breast Cancer: Targets and Therapy.2023; Volume 15: 251. CrossRef
Risk of Metabolic Syndrome and Fatty Liver Diseases in Gastric Cancer Survivors: A Propensity Score-Matched Analysis
Sang Jo Han, Su Jung Baik, Young Hoon Yoon, Jie Hyun Kim, Hye Sun Lee, Soyoung Jeon, Hyojin Park
The Korean Journal of Gastroenterology.2023; 81(4): 154. CrossRef
Photonic Nanoparticles: Emerging Theranostics in Cancer Treatment
Seyed Hossein Shahcheraghi, Seyed Hadi Shahcheraghi, Marzieh Lotfi, Malihe Lotfi, Seyed Hossein Khaleghinejad, Zara M Tambuwala, Vijay Mishra, Yachana Mishra, Ángel Serrano-Aroca, Alaa A A Aljabali, Mohamed El-Tanani, Gowhar A Naikoo, Sai Raghuveer Chava,
Therapeutic Delivery.2023; 14(4): 311. CrossRef
Is Fragmented Cancer Care Associated With Medical Expenditure? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data
Kyu-Tae Han, Sun Jung Kim
International Journal of Public Health.2023;[Epub] CrossRef
Cancer Statistics in Pakistan From 1994 to 2021: Data From Cancer Registry
Muhammad Tufail, Changxin Wu
JCO Clinical Cancer Informatics.2023;[Epub] CrossRef
Fear of cancer recurrence in South Korean survivors of breast cancer who have received adjuvant endocrine therapy: a cross-sectional study
Seul Ki Park, Yul Ha Min
Frontiers in Psychology.2023;[Epub] CrossRef
The effects of hospice care on healthcare expenditure among cancer patients
Hoyol Jhang, Wonjeong Jeong, Hyun-Soo Zhang, Dong-Woo Choi, Hyejung Kang, Sohee Park
BMC Health Services Research.2023;[Epub] CrossRef
Single omental metastasis of renal cell carcinoma after radical nephrectomy: A case report
Jae-Wook Chung, Jun-Koo Kang, Eun Hye Lee, So Young Chun, Yun-Sok Ha, Jun Nyung Lee, Tae-Hwan Kim, Tae Gyun Kwon, Ghil Suk Yoon
World Journal of Clinical Cases.2023; 11(25): 5994. CrossRef
Risk Factors and Prognosis of Stroke in Gynecologic Cancer Patients
Ji Young Kwon, Kena Park, Jeong Min Song, Seung Yeon Pyeon, Seon Hwa Lee, Young Shin Chung, Jong-Min Lee
Cancers.2023; 15(19): 4895. CrossRef
Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
Eun-Gyeong Lee, Jiwon Lim, Hyeong In Ha, Myong Cheol Lim, Yoon Jung Chang, Young-Joo Won, So-Youn Jung
Frontiers in Oncology.2023;[Epub] CrossRef
Effect of chronic viral hepatitis and metabolic factors on renal cancer risk in a large cohort in Republic of Korea
Hoyoung Wang, Su Youn Nam, Junwoo Jo
Preventive Medicine.2023; 175: 107714. CrossRef
Prostate cancer in workers exposed to night-shift work: two cases recognized by the Korean Epidemiologic Investigation Evaluation Committee
Sungkyun Park, Seongwon Ma, Hoekyeong Seo, Sang Gil Lee, Jihye Lee, Shinhee Ye
Annals of Occupational and Environmental Medicine.2023;[Epub] CrossRef
Specificities of childhood tumours and the paediatric oncology service in the context of decentralisation
Ion Mereuta, Eugeniu Valic
Bulletin of the Academy of Sciences of Moldova. Medical Sciences.2023; 76(2): 109. CrossRef
Estrogen exposure causes the progressive growth of SK-Hep1-derived tumor in ovariectomized mice
Sungryong Oh, Hee Jung Kwon, Joohee Jung
Toxicological Research.2022; 38(1): 1. CrossRef
Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma
X. Wei, Y. Min, Y. Feng, D. He, X. Zeng, Y. Huang, S. Fan, H. Chen, J. Chen, K. Xiang, H. Luo, G. Yin, D. Hu
Journal of Endocrinological Investigation.2022; 45(3): 507. CrossRef
Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia
Yung‐Taek Ouh, Ji Jeong Park, Minjoo Kang, Miseon Kim, Jae Yun Song, So Jin Shin, Seung‐Hyuk Shim, Heon Jong Yoo, Maria Lee, Sung‐Jong Lee, Whan Shin, Gun Oh. Chong, Min Chul Choi, Chel Hun Choi, Kyung‐Jin Min
Journal of Obstetrics and Gynaecology Research.2022; 48(1): 207. CrossRef
Loss of adipose tissue or skeletal muscle during first‐line gemcitabine/nab‐paclitaxel therapy is associated with worse survival after second‐line therapy of advanced pancreatic cancer
Masami Miki, Lingaku Lee, Terumasa Hisano, Rie Sugimoto, Masayuki Furukawa
Asia-Pacific Journal of Clinical Oncology.2022;[Epub] CrossRef
Quality of Life and Prolonged Symptoms in Korean Breast Cancer Survivors
Min Kyeong Jang, Sue Kim, Chang Gi Park, Eileen G. Collins, Lauretta T. Quinn, Carol Estwing Ferrans
Cancer Nursing.2022; 45(1): E124. CrossRef
Cancer-Specific Survival Outcome in Early-Stage Young Breast Cancer: Evidence From the SEER Database Analysis
Rui Liu, Zhesi Xiao, Daixing Hu, Haojun Luo, Guobing Yin, Yang Feng, Yu Min
Frontiers in Endocrinology.2022;[Epub] CrossRef
Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study
Se Young Choi, Moon Soo Ha, Byung Hoon Chi, Jin Wook Kim, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung, Myoungsuk Kim, Kyung-Eun Lee, Yuwon Kim, Hyun-Ki Woo, Dae-Sung Kyoung, Hasung Kim
Journal of Cancer Research and Clinical Oncology.2022; 148(11): 3135. CrossRef
Pilot study of the Korean national breast implant registry: Experiences and lessons learned
W.J. Song, S.G. Kang, B.M.F. Seo, N.K. Choi, J.H. Lee
Journal of Plastic, Reconstructive & Aesthetic Surgery.2022; 75(6): 1833. CrossRef
MHY2245, a Sirtuin Inhibitor, Induces Cell Cycle Arrest and Apoptosis in HCT116 Human Colorectal Cancer Cells
Yong Jung Kang, Jung Yoon Jang, Young Hoon Kwon, Jun Ho Lee, Sanggwon Lee, Yujin Park, Young-Suk Jung, Eunok Im, Hyung Ryong Moon, Hae Young Chung, Nam Deuk Kim
International Journal of Molecular Sciences.2022; 23(3): 1590. CrossRef
Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer
Yu Min, Yang Feng, Haojun Luo, Daixing Hu, Xiaoyuan Wei, Danshuang He, Guobing Yin, Shenghao Fan
Frontiers in Endocrinology.2022;[Epub] CrossRef
Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study
Dong Wook Shin, Kyu-Won Jung, Johyun Ha, Jaeman Bae
Journal of Gynecologic Oncology.2022;[Epub] CrossRef
A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer
H. Jo, M.-S. Lee, Y.-P. Lee, H. Kim, J.Y. Hong, J. Lee, S.H. Park, J.O. Park, Y.S. Park, H.Y. Lim, W.K. Kang, S.T. Kim
Clinical Oncology.2022; 34(8): e323. CrossRef
Dysregulated LINC00961 Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p
Jing Sui, Qun Zhao, Yanqiu Zhang, Geyu Liang
DNA and Cell Biology.2022; 41(3): 319. CrossRef
Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study
Yang Ou, Yichen Long, Lili Ji, Yanxia Zhan, Tiankui Qiao, Xiangdong Wang, Hao Chen, Yunfeng Cheng
Frontiers in Oncology.2022;[Epub] CrossRef
Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database
Zhuowei Tang, Yuzhu Ji, Yu Min, Xiaohong Zhang, Weiyun Xu, Lijuan Zhao, Jing Zhang, Li Long, Jing Feng, Yixue Wen
Frontiers in Endocrinology.2022;[Epub] CrossRef
Association between gastric cancer and the risk of depression among South Korean adults
Sinyoung Kwon, Jinyeong Kim, Taeyeon Kim, Wonjeong Jeong, Eun-Cheol Park
BMC Psychiatry.2022;[Epub] CrossRef
Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study
Oh. Hyeong Lee, Yong-Moon Park, Seung-Hyun Ko, Kyuna Lee, Yeonji Kim, Kyungdo Han, Jung-Hae Cho
BMC Cancer.2022;[Epub] CrossRef
Do we need to adjust the effect-site concentration of propofol in patients undergoing chemotherapy?
Ki Tae Jung
Korean Journal of Anesthesiology.2022; 75(2): 109. CrossRef
Apoptotic Effects of Butanol Fraction of Lysimachia foenum-graecum by Regulating Akt/mTOR Signaling Pathways in AGS Gastric Cancer Cells
Hyo Jae Lee, Ji Won Seo, Sang Hyeon Kim, Chang Yeol Lee, Sang Yong Kim, Young Min Kim
Journal of the Korean Society of Food Science and Nutrition.2022; 51(3): 221. CrossRef
Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study
Jinyoung Shin, Dong Wook Shin, Jungkwon Lee, JiHye Hwang, Ji Eun Lee, BeLong Cho, Yun–Mi Song
BMC Cancer.2022;[Epub] CrossRef
Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer
Chung-Un Lee, Wan Song, Michael Jakun Koo, Youngjun Boo, Jae-Hoon Chung, Minyong Kang, Hyun-Hwan Sung, Hwang-Gyun Jeon, Byong-Chang Jeong, Seong-Il Seo, Hyun-Moo Lee, Jeongyun Jeong, SeongSoo Jeon
Diagnostics.2022; 12(5): 1040. CrossRef
The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
Mengbao Du, Weiwei Chen, Ke Liu, Limengmeng Wang, Yihan Hu, Yingying Mao, Xiaohui Sun, Yi Luo, Jimin Shi, Keding Shao, He Huang, Ding Ye, Irena Ilic
Journal of Oncology.2022; 2022: 1. CrossRef
Association of institutional transition of cancer care with mortality in elderly patients with lung cancer: a retrospective cohort study using national claim data
Kyu-Tae Han, Jongwha Chang, Dong-Woo Choi, Seungju Kim, Dong Jun Kim, Yoon-Jung Chang, Sun Jung Kim
BMC Cancer.2022;[Epub] CrossRef
Anti-cancer effect of glabridin by reduction of extracellular vesicles secretion in MDA-MB-231 human breast cancer cells
Sang-Hun Choi, Jin-Hyeon Hwang, Moon-Chang Baek, Young-Eun Cho
Journal of Nutrition and Health.2022; 55(2): 240. CrossRef
Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation
Ji Soo Park, Jung Won Park, Saeam Shin, Seung-Tae Lee, Sang Joon Shin, Byung Soh Min, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
Diseases of the Colon & Rectum.2022; 65(6): 793. CrossRef
Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
Jung Rae Cho, Keun-Wook Lee, Heung-Kwon Oh, Jin Won Kim, Ji-Won Kim, Duck-Woo Kim, Jee Hyun Kim, Sung-Bum Kang
Annals of Surgical Treatment and Research.2022; 102(5): 271. CrossRef
Hospital case-volume and mortality after lung cancer surgery: A population-based retrospective cohort study
Bo Rim Kim, Jin Young Sohn, Eun Jin Jang, Junwoo Jo, Hannah Lee, Ho Geol Ryu
Lung Cancer.2022; 169: 61. CrossRef
Pancreatic ductal adenocarcinoma with a predominant large duct pattern has better recurrence-free survival than conventional pancreatic ductal adenocarcinoma: a comprehensive histopathological, immunohistochemical, and mutational study
Sung Joo Kim, Se Jin Choi, Junmo Yang, Deokhoon Kim, Dong Wook Kim, Jae Ho Byun, Seung-Mo Hong
Human Pathology.2022; 127: 39. CrossRef
Association of Metabolic Health and Central Obesity with the Risk of Thyroid Cancer: Data from the Korean Genome and Epidemiology Study
Dung N. Nguyen, Jin Hee Kim, Mi Kyung Kim
Cancer Epidemiology, Biomarkers & Prevention.2022; 31(3): 543. CrossRef
Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South Korea
HyunA Jo, Se Ik Kim, Wenyu Wang, Aeran Seol, Youngjin Han, Junhwan Kim, In Sil Park, Juwon Lee, Juhwan Yoo, Kyung-Do Han, Yong Sang Song
Frontiers in Oncology.2022;[Epub] CrossRef
Anti-adhesive effect and safety of a thermosensitive adhesion barrier (Mediclore) for thyroid surgery: a double-blinded randomized controlled trial
Jong-hyuk Ahn, Sang Gab Yoon, Jin Wook Yi, Su-jin Kim, Kyu Eun Lee
Annals of Surgical Treatment and Research.2022; 102(6): 313. CrossRef
Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
Journal of Korean Medical Science.2022;[Epub] CrossRef
A Case Report of Symptom Improvement with Recurrent Gallbladder Cancer Patients Treated with Korean Medicine-based Integrative Cancer Treatment
Eun-ju Ko, Sung-kuk Do, Ji-hye Park, Si-yeon Song, Yeon-weol Lee, Hwa-seung Yoo
The Journal of Internal Korean Medicine.2022; 43(3): 477. CrossRef
Target nursing care on anxiety and depression in patients with gallbladder cancer during perioperative period
Shuang Liu, Li Zhang, Xiu-e Guan, Lei Zhang, Rui Wang
Medicine.2022; 101(31): e29883. CrossRef
Low-Level Environmental Mercury Exposure and Thyroid Cancer Risk Among Residents Living Near National Industrial Complexes in South Korea: A Population-Based Cohort Study
Seyoung Kim, Sang-Hwan Song, Chul-Woo Lee, Jung-Taek Kwon, Eun Young Park, Jin-Kyoung Oh, Hyun-Jin Kim, Eunjung Park, Byungmi Kim
Thyroid.2022; 32(9): 1118. CrossRef
Acupuncture for hot flashes in hormone receptor-positive breast cancer, a coordinated multinational study: Rationale and design of the study protocol
Weidong Lu, Anita Giobbie-Hurder, Anna Tanasijevic, Sylvia Baedorf Kassis, Sung Hwan Park, Young Ju Jeong, Im Hee Shin, Chang Yao, Hyun Jung Jung, Zhiyuan Zhu, Chao Bao, Eun Mee Yang, Barbara E. Bierer, Jennifer A. Ligibel
Contemporary Clinical Trials.2022; 121: 106885. CrossRef
The efficiency and safety of immune checkpoint inhibitors for advanced biliary tract cancers based on gene profiles: A retrospectively controlled study
G.L. Yao, Y.G. Fan
Medicine.2022; 101(37): e30443. CrossRef
Association of Glycosylated Hemoglobin Level and Cancer-Related Mortality in Patients without Diabetes
Tae Kyung Yoo, Mi Yeon Lee, Sul A. Lee, Eun Sun Cheong, Mi Hae Seo, Ki Chul Sung
Journal of Clinical Medicine.2022; 11(19): 5933. CrossRef
A scoping review on population-centered indicators for cancer care continuum
Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun
Frontiers in Public Health.2022;[Epub] CrossRef
Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced‐stage EGFR‐mutated non‐small‐cell lung cancer
Taeyun Kim, Sang Jin Lee, Tae‐Won Jang
Thoracic Cancer.2022; 13(23): 3353. CrossRef
Impact of modifiable reproductive factors on cancer incidence and mortality in Korea: a systematic review protocol
Seo-Hee Kim, Mi Ah Han
BMJ Open.2022; 12(11): e067826. CrossRef
Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older
Youjin Hong, Sangjun Lee, Sungji Moon, Soseul Sung, Woojin Lim, Kyungsik Kim, Seokyung An, Jeoungbin Choi, Kwang-Pil Ko, Inah Kim, Jung Eun Lee, Sue K. Park
Journal of Preventive Medicine and Public Health.2022; 55(6): 529. CrossRef
Sex-dependent associations between MAP3K1 gene polymorphisms and soy products with the gastric cancer risk in Korea: a case-control study
Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
BMC Gastroenterology.2022;[Epub] CrossRef
Effect of Hospital Case-Volume on Mortality after Ovarian Cancer Surgery: A Population-Based Retrospective Cohort Study
Bo Rim Kim, Heewon Kim, Se-gyeong Joo, Eun Jin Jang, Junwoo Jo, Hannah Lee, Ho Geol Ryu
Gynecologic and Obstetric Investigation.2022; 87(6): 364. CrossRef
Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A
Cheol‐Kyu Park, Sung‐Yong Lee, Jae Cheol Lee, Chang‐Min Choi, Shin Yup Lee, Tae‐Won Jang, In‐Jae Oh, Young‐Chul Kim
Thoracic Cancer.2021; 12(4): 444. CrossRef
Differences in Dietary Patterns Identified by the Gaussian Graphical Model in Korean Adults With and Without a Self-Reported Cancer Diagnosis
Tung Hoang, Jeonghee Lee, Jeongseon Kim
Journal of the Academy of Nutrition and Dietetics.2021; 121(8): 1484. CrossRef
New Polyenes from the Marine-Derived Fungus Talaromyces cyanescens with Anti-Neuroinflammatory and Cytotoxic Activities
Hee Jae Shin, Cao Van Anh, Duk-Yeon Cho, Dong-Kug Choi, Jong Soon Kang, Phan Thi Hoai Trinh, Byeoung-Kyu Choi, Hwa-Sun Lee
Molecules.2021; 26(4): 836. CrossRef
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)
H.S. Park, B. Kang, H.J. Chon, H.-S. Im, C.-K. Lee, I. Kim, M.J. Kang, J.E. Hwang, W.K. Bae, J. Cheon, J.O. Park, J.Y. Hong, J.H. Kang, J.H. Kim, S.H. Lim, J.W. Kim, J.-W. Kim, C. Yoo, H.J. Choi
ESMO Open.2021; 6(2): 100049. CrossRef
Artificial intelligence in breast ultrasonography
Jaeil Kim, Hye Jung Kim, Chanho Kim, Won Hwa Kim
Ultrasonography.2021; 40(2): 183. CrossRef
Relationship Between Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol and Lung Cancer Risk in the General Population: A Community-Based Prospective Cohort Study
Eun Young Park, Min Kyung Lim, Eunjung Park, Jin-Kyoung Oh, Do-Hoon Lee
Frontiers in Oncology.2021;[Epub] CrossRef
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
Changhoon Yoo, Sang Hyun Shin, Joon-Oh Park, Kyu-Pyo Kim, Jae Ho Jeong, Baek-Yeol Ryoo, Woohyung Lee, Ki-Byung Song, Dae-Wook Hwang, Jin-hong Park, Jae Hoon Lee
Cancers.2021; 13(7): 1647. CrossRef
Occupational and environmental asbestos exposure and the risk of lung cancer in Korea: A case-control study in South Chungcheong Province of Korea
Da-An Huh, Min-Sung Kang, Jiyun Lee, Ji Yoon Choi, Kyong Whan Moon, Yong-Jin Lee, Flavio Manoel Rodrigues Da Silva Júnior
PLOS ONE.2021; 16(4): e0249790. CrossRef
Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial
Chang Woo Kim, Hyunjin Kim, Hyoung Rae Kim, Bong-Hyeon Kye, Hyung Jin Kim, Byung Soh Min, Tae Jeong Oh, Sungwhan An, Suk-Hwan Lee
BMC Gastroenterology.2021;[Epub] CrossRef
Association among Body Mass Index, Genetic Variants of FTO, and Thyroid Cancer Risk: A Hospital-Based Case-Control Study of the Cancer Screenee Cohort in Korea
Tung Hoang, Dayoung Song, Jeonghee Lee, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
Cancer Research and Treatment.2021; 53(3): 857. CrossRef
Risk of female-specific cancers according to obesity and menopausal status in 2•7 million Korean women: Similar trends between Korean and Western women
In Sil Park, Se Ik Kim, Youngjin Han, Juhwan Yoo, Aeran Seol, HyunA Jo, Juwon Lee, Wenyu Wang, Kyungdo Han, Yong Sang Song
The Lancet Regional Health - Western Pacific.2021; 11: 100146. CrossRef
Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells
Hye-yon Cho, Yong-Beom Kim, Wook-ha Park, Jae Hong No
Cancer Research and Treatment.2021; 53(3): 819. CrossRef
Enhanced Susceptibility to Breast Cancer in Korean Women With Elevated Serum Gamma-Glutamyltransferase Levels: A Nationwide Population-Based Cohort Study
Aeran Seol, Wenyu Wang, Se Ik Kim, Youngjin Han, In Sil Park, Juhwan Yoo, HyunA Jo, Kyung-Do Han, Yong Sang Song
Frontiers in Oncology.2021;[Epub] CrossRef
Screening and Eradication of Helicobacter pylori for Gastric Cancer Prevention
Hyunchul Lim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(2): 168. CrossRef
Body weight variability and cancer incidence in men aged 40 years and older-Korean National Insurance Service Cohort
Yu Jin Cho, Jin Seul Kawk, Hyung-Jin Yoon, Minseon Park
Scientific Reports.2021;[Epub] CrossRef
Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients?
Kyu-Tae Han, Woorim Kim, Areum Song, Yeong Jun Ju, Dong-Woo Choi, Seungju Kim
Health Policy.2021; 125(8): 1047. CrossRef
IGF2BP1 IS A POOR PROGNOSTIC FACTOR IN EXTRAHEPATIC CHOLANGIOCARCINOMA
Hung-Chune Maa, Yi-No Wu
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021; : 80. CrossRef
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells
Da-Young Lee, Moon-Young Song, Eun-Hee Kim
Journal of Cancer Prevention.2021; 26(2): 137. CrossRef
Clinical characteristics of patients in their forties who underwent surgical resection for colorectal cancer in Korea
Chang Sin Lee, Se-Jin Baek, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim
World Journal of Gastroenterology.2021; 27(25): 3901. CrossRef
Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
Cancer Research and Treatment.2021; 53(3): 650. CrossRef
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Wei Chen, Yu kun Luo, Ying Zhang, Qing Song, Jie Tang
BMC Cancer.2021;[Epub] CrossRef
Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma
You-Na Sung, Sung Joo Kim, Sun-Young Jun, Changhoon Yoo, Kyu-Pyo Kim, Jae Hoon Lee, Dae Wook Hwang, Shin Hwang, Sang Soo Lee, Seung-Mo Hong
Frontiers in Oncology.2021;[Epub] CrossRef
The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer
Jae-Wook Chung, Yun-Sok Ha, Sang Won Kim, Seung Chol Park, Taek Won Kang, Young Beom Jeong, Sung-Woo Park, Jinsung Park, Eun Sang Yoo, Tae Gyun Kwon, Sung Pil Seo, Ho Won Kang, Won Tae Kim, Yong-June Kim, Sang-Cheol Lee, Wun-Jae Kim, Seok Joong Yun, Tae-H
Investigative and Clinical Urology.2021; 62(5): 545. CrossRef
The association between hospital case‐volume and postoperative outcomes after esophageal cancer surgery: A population‐based retrospective cohort study
Bo Rim Kim, Eun Jin Jang, Junwoo Jo, Hannah Lee, Dong Yeon Jang, Ho Geol Ryu
Thoracic Cancer.2021; 12(18): 2487. CrossRef
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis
Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon
Therapeutic Advances in Medical Oncology.2021;[Epub] CrossRef
Development and validation of a population-based model for predicting the regional lymph node metastasis in adolescent differentiated thyroid carcinoma
Yu Min, Ke Xiang, Yang Feng, Hang Chen, Jialin Chen, Xiaoyuan Wei, Guobing Yin
Oral Oncology.2021; 121: 105507. CrossRef
Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer
Chang Woo Kim, Hong Jae Chon, Chan Kim
Cancers.2021; 13(19): 4906. CrossRef
Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast Cancer Patients Without Lymph Node Metastasis
Yu Min, Xiaoman Liu, Daixing Hu, Hang Chen, Jialin Chen, Ke Xiang, Guobing Yin, Yuling Han, Yang Feng, Haojun Luo
Frontiers in Endocrinology.2021;[Epub] CrossRef
Clinical Application of Automated Breast Ultrasound
Sung Hun Kim
Clinical Ultrasound.2021; 6(2): 35. CrossRef
The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells
Tin Myo Khing, Won Seok Choi, Dong Min Kim, Wah Wah Po, Wynn Thein, Chang Yell Shin, Uy Dong Sohn
Scientific Reports.2021;[Epub] CrossRef
The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers
Hye Ryeon Kim, Soomin Ahn, Hyunji Jo, Hongsik Kim, Joohyun Hong, Jeeyun Lee, Ho-Yeong Lim, Won Ki Kang, Seung Tae Kim
Frontiers in Oncology.2021;[Epub] CrossRef
New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, Mee-Sun Moon, Yoon-Koo Kang
World Journal of Gastroenterology.2021; 27(48): 8357. CrossRef
Clinical relevance and prognostic role of preoperative cell-free single-stranded DNA concentrations in colorectal cancer patients
Hyun Soo Song, Dong Hyun Kang, Hyunjung Kim, Tae Sung Ahn, Tae Wan Kim, Moo-Jun Baek
Korean Journal of Clinical Oncology.2021; 17(2): 59. CrossRef
Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer
Si-Hyong Jang, Ji-Hye Lee, Hyun Ju Lee, Hyundeuk Cho, Hyein Ahn, In Hag Song, Mee-Hye Oh
Pathology - Research and Practice.2020; 216(11): 153156. CrossRef
Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations
Elisha Goldstein, Kristina Yeghiazaryan, Ashar Ahmad, Frank A. Giordano, Holger Fröhlich, Olga Golubnitschaja
EPMA Journal.2020; 11(3): 505. CrossRef
FERMT1 promotes gastric cancer progression by activating the NF-κB pathway and predicts poor prognosis
Hua Fan, Shengjun Zhang, Yu Zhang, Wu liang, Bo Cao
Cancer Biology & Therapy.2020; 21(9): 815. CrossRef
Imipramine Inhibits Migration and Invasion in Metastatic Castration-Resistant Prostate Cancer PC-3 Cells via AKT-Mediated NF-κB Signaling Pathway
Eun Yeong Lim, Joon Park, Yun Tai Kim, Min Jung Kim
Molecules.2020; 25(20): 4619. CrossRef
Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
Min Chul Choi, Yong-Man Kim, Jeong-Won Lee, Yong Jae Lee, Dong Hoon Suh, Sung Jong Lee, Taek Sang Lee, Maria Lee, Dong Choon Park, Min Kyu Kim, Jong-Min Lee, Seung-Hyuk Shim, Seob Jeon, Kyung Jin Min, Mi Kyung Kim, Bo Wook Kim, Jeong Yeol Park, Byoung-Gie
Cancers.2020; 12(11): 3188. CrossRef
PAK1 as a Potential Therapeutic Target in Male Smokers with EGFR-Mutant Non-Small Cell Lung Cancer
Jae Heun Chung, Taehwa Kim, Yong Jung Kang, Seong Hoon Yoon, Yun Seong Kim, Sung Kwang Lee, Joo Hyung Son, Bongsoo Son, Do Hyung Kim
Molecules.2020; 25(23): 5588. CrossRef
Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer
Woosung Son, Su-Jin Shin, Su Hyeong Park, Soo Kyung Lee, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang
Diagnostics.2020; 10(11): 859. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Prediction of Cancer Incidence and Mortality in Korea, 2020

Cancer Res Treat. 2020;52(2):351-358. Published online March 16, 2020

DOI: https://doi.org/10.4143/crt.2020.203

XML Download

Abstract
Introduction
Materials and Methods
Results
Conclusion
NOTES
REFERENCES

Prediction of Cancer Incidence and Mortality in Korea, 2020

Fig. 1. The 10 leading types of estimated new cancer cases and deaths by sex in 2020. (A) Estimated new cases. (B) Estimated deaths.

Fig. 2. Projected age-specific incidences of major cancers during 2020 in Korea. (A) Men. (B) Women.

Fig. 3. Projected age-specific mortality rates of major cancers during 2020 in Korea. (A) Men. (B). Women.

Fig. 1.

Fig. 2.

Fig. 3.

Prediction of Cancer Incidence and Mortality in Korea, 2020

Site	Estimated new cases			Estimated deaths
Site	Both sexes	Men	Women	Both sexes	Men	Women
All sites	243,263	126,098	117,165	80,546	49,284	31,262
Lip, oral cavity, and pharynx	3,915	2,813	1,102	1,222	888	334
Esophagus	2,555	2,317	238	1,278	1,140	138
Stomach	27,005	17,889	9,116	6,279	4,060	2,219
Colon and rectum	25,881	14,789	11,092	8,758	4,847	3,911
Liver^a)	14,670	10,994	3,676	9,961	7,090	2,871
Gallbladder^b)	7,999	4,244	3,755	5,235	2,809	2,426
Pancreas	8,331	4,330	4,001	6,843	3,483	3,360
Larynx	1,085	1,020	65	266	252	14
Lung^c)	29,292	20,340	8,952	18,796	14,192	4,604
Breast	25,549	97	25,452	2,766	18	2,748
Cervix uteri	3,148	-	3,148	801	-	801
Corpus uteri	3,261	-	3,261	383	-	383
Ovary	2,941	-	2,941	1,309	-	1,309
Prostate	14,561	14,561	-	2,040	2,040	-
Testis	308	308	-	18	18	-
Kidney	5,923	4,003	1,920	1,198	813	385
Bladder	4,832	3,870	962	1,622	1,229	393
Brain and CNS	2,122	1,140	982	1,351	703	648
Thyroid	26,747	5,884	20,863	350	100	250
Hodgkin lymphoma	342	214	128	72	43	29
Non-Hodgkin lymphoma	5,484	3,161	2,323	2,145	1,230	915
Multiple myeloma	1,963	1,019	944	1,153	624	529
Leukemia	3,766	2,167	1,599	2,041	1,187	854
Other and ill defined	21,583	10,938	10,645	4,659	2,518	2,141

Site	Crude incidence rate per 100,000			Age-standardized incidence rate per 100,000^a)
Site	Both sexes	Men	Women	Both sexes	Men	Women
All sites	469.2	487.5	450.9	253.7	268.7	250.9
Lip, oral cavity, and pharynx	7.6	10.9	4.2	4.2	6.2	2.4
Esophagus	4.9	9.0	0.9	2.4	4.6	0.4
Stomach	52.1	69.2	35.1	27.1	37.2	16.5
Colon and rectum	49.9	57.2	42.7	24.2	30.5	18.3
Liver^b)	28.3	42.5	14.2	14.8	22.9	6.0
Gallbladder^c)	15.4	16.4	14.5	6.7	8.3	5.4
Pancreas	16.1	16.7	15.4	7.3	8.8	6.2
Larynx	2.1	3.9	0.3	1.1	2.0	0.1
Lung^d)	56.5	78.6	34.5	25.9	39.9	15.2
Breast	49.3	0.4	98.0	29.3	0.2	61.0
Cervix uteri	6.1	-	12.1	3.5	-	7.8
Corpus uteri	6.3	-	12.6	3.6	-	7.6
Ovary	5.7	-	11.3	3.4	-	7.0
Prostate	28.1	56.3	-	12.4	28.7	-
Testis	0.6	1.2	-	0.6	1.2	-
Kidney	11.4	15.5	7.4	6.2	9.1	4.0
Bladder	9.3	15.0	3.7	4.3	7.6	1.5
Brain and CNS	4.1	4.4	3.8	3.0	3.3	2.7
Thyroid	51.6	22.8	80.3	36.4	16.0	57.5
Hodgkin lymphoma	0.7	0.8	0.5	0.6	0.7	0.5
Non-Hodgkin lymphoma	10.6	12.2	8.9	6.3	7.9	5.1
Multiple myeloma	3.8	3.9	3.6	1.9	2.1	1.6
Leukemia	7.3	8.4	6.2	5.5	6.6	4.6
Other and ill defined	41.6	42.3	41.0	22.1	24.8	19.5

Rank	Age group (yr)
Rank	0-14	15-34	35-64	≥ 65
Men
1	Leukemia (4.9)	Thyroid (13.7)	Stomach (66.3)	Lung^a) (428.6)
2	Non-Hodgkin lymphoma (3.1)	Leukemia (3.8)	Colon and rectum (48.3)	Prostate (323.0)
3	Brain and CNS (2.3)	Non-Hodgkin lymphoma (3.2)	Liver^b) (44.2)	Stomach (276.7)
4	Kidney (0.4)	Testis (2.7)	Lung^a) (43.8)	Colon and rectum (248.7)
5	Liver^b) (0.3)	Colon and rectum (2.4)	Prostate (27.2)	Liver^b) (156.8)
Women
1	Leukemia (4.0)	Thyroid (50.0)	Breast (164.1)	Colon and rectum (157.3)
2	Brain and CNS (2.1)	Breast (12.0)	Thyroid (126.6)	Lung^a) (124.3)
3	Non-Hodgkin lymphoma (1.7)	Cervix uteri (5.5)	Stomach (31.7)	Stomach (112.3)
4	Ovary (0.8)	Ovary (3.4)	Colon and rectum (30.9)	Breast (101.3)
5	Thyroid (0.7)	Corpus uteri (2.5)	Lung^a) (26.3)	Gallbladder^c) (65.6)

Site	Crude mortality rate per 100,000			Age-standardized mortality rate per 100,000^a)
Site	Both sexes	Men	Women	Both sexes	Men	Women
All sites	155.3	190.5	120.3	69.4	98.0	48.2
Lip, oral cavity, and pharynx	2.4	3.4	1.3	1.1	1.8	0.6
Esophagus	2.5	4.4	0.5	1.1	2.2	0.2
Stomach	12.1	15.7	8.5	5.3	8.1	3.1
Colon and rectum	16.9	18.7	15.1	7.2	9.6	5.2
Liver^b)	19.2	27.4	11.1	9.0	14.6	4.0
Gallbladder^c)	10.1	10.9	9.3	4.1	5.4	3.0
Pancreas	13.2	13.5	12.9	5.8	7.0	4.8
Larynx	0.5	1.0	0.1	0.2	0.5	0.0
Lung^d)	36.3	54.9	17.7	15.2	27.2	6.3
Breast	5.3	0.1	10.6	3.1	0.0	6.1
Cervix uteri	1.5	-	3.1	0.9	-	1.7
Corpus uteri	0.7	-	1.5	0.4	-	0.8
Ovary	2.5	-	5.0	1.3	-	2.5
Prostate	3.9	7.9	-	1.4	3.7	-
Testis	0.0	0.1	-	0.0	0.1	-
Kidney	2.3	3.1	1.5	1.1	1.7	0.6
Bladder	3.1	4.8	1.5	1.2	2.3	0.4
Brain and CNS	2.6	2.7	2.5	1.6	1.8	1.4
Thyroid	0.7	0.4	1.0	0.3	0.2	0.3
Hodgkin lymphoma	0.1	0.2	0.1	0.1	0.1	0.1
Non-Hodgkin lymphoma	4.1	4.8	3.5	1.9	2.5	1.4
Multiple myeloma	2.2	2.4	2.0	1.0	1.2	0.8
Leukemia	3.9	4.6	3.3	2.1	2.7	1.6
Other and ill defined	9.0	9.7	8.2	4.2	5.3	3.3

Table 1. Estimated new cancer cases and deaths by sex during 2020 in Korea

CNS, central nervous system.

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.

Table 2. Estimated crude and age-standardized cancer incidences by sex during 2020 in Korea

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.

Table 3. Estimated cancer incidence by age group and sex during 2020 in Korea

CNS, central nervous system.

Includes the lung and bronchus,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 4. Estimated crude and age-standardized cancer mortality rates by sex during 2020 in Korea

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.